Hereditary Sensory and Autonomic Neuropathy (HSAN) type IA and IC are caused by 28 elevated levels of an atypical class of lipid named 1-deoxysphingolipid (DoxSL). How 29 elevated levels of DoxSL perturb the physiology of the cell and how the perturbations lead to 30 HSAN IA/C are largely unknown. In this study, we show that C 26 -1-deoxydihydroceramide 31 (C 26 -DoxDHCer) is highly toxic to the cell, while C 16 -and C 18 -DoxDHCer are less toxic. 32 Genome-wide genetic screens and lipidomics revealed the dynamics of DoxSL accumulation 33 and DoxSL species responsible for the toxicity over the course of DoxSL accumulation. 34 Furthermore, we show that disruption of F-actin organization, alteration of mitochondrial 35 shape, and accumulation of hydrophobic bodies by DoxSL are not sufficient to cause 36 complete cellular failure. However, combined with collapsed ER membrane, these 37 perturbations cause cell death. Thus, we have unraveled key principles of DoxSL cytotoxicity 38 that help to explain the clinical features of HSAN IA/C. 39 40 42 functions of the peripheral nervous system. The clinical hallmark of the diseases is loss of 43 pain and temperature sensations in the distal extremities. In some cases, it is accompanied by 44 hypohidrosis (diminished sweating) [1]. In general, the diseases have a late onset varying 45 between the second and the fifth decade of life [1], although cases with a congenital or 46 childhood onset have been reported [2, 3]. The progression of the diseases is usually slow. As 47 the diseases progress, the affected individuals often develop complications, such as ulcerative 48 mutilations; muscle wasting and weakness; reduced motor functions; and spontaneous 49
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41
HSAN type IA and IC are inherited diseases that mainly affect the sensory and autonomic 6 consistent with the recent finding that Lag1p prefers phytosphingosine to Sa as a substrate 126 (Megyeri et al., 2019, in press), and therefore is expected to have reduced activity towards 127 DoxSa or DoxmetSa. 7 DoxmetSa to 1-deoxymethyldihydroceramide (DoxmetDHCer) or that DoxmetSa is toxic on 151 its own. Therefore, we cannot evaluate the toxicity of different DoxmetDHCer species. 152 To determine the species and the levels of accumulated DoxDHCer in cells for a given 153 concentration of DoxSa, we treated the strains with DoxSa in a liquid medium at a non-toxic 154 condition (low DoxSa concentration, high cell density, one yeast generation time) and then 155 measured the levels of sphingolipid in the cells by mass spectrometry (MS). A non-toxic 156 condition was chosen to ensure that the cells were not saturated with DoxDHCer, therefore 157 allowing comparison between the levels of accumulated DoxDHCer in different strains. The 158 MS analysis showed that DoxSa had a minor effect on the levels of typical sphingolipid 159 (S1B- H Fig) , demonstrating that the treatment condition is not toxic to the cells. The analysis 160 also showed that following the DoxSa treatment, the strain expressing CerS3 mainly 161 accumulated C 26 -DoxDHCer. Interestingly, the level of C 26 -DoxDHCer in the strain was 162 much higher than that in WT, indicating that the mammalian CerS3, which makes the same 163 DHCer species as the yeast ceramide synthase, is more efficient in producing C 26 -DoxDHCer 164 than the yeast enzyme. Moreover, the level of C 26 -DoxDHCer in the strain was lower than 165 those of C 16 -DoxDHCer in the strains expressing CerS5 or 6 and those of C 18 -DoxDHCer in 166 the strains expressing CerS1 or 4 (Fig 2E) . Nevertheless, the strain expressing CerS3 was the 167 most sensitive strain to DoxSa (Fig 2C) . These results strongly indicate that C 26 -DoxDHCer 168 is more toxic than C 16 -or C 18 -DoxDHCer.
170
Genome-wide genetic screen of knockout and hypomorphic (DAmP) mutants 171 To gain insights into the mechanism of action (MoA) of DoxSL, we performed a genome-172 wide genetic screen for gene products whose absence or deficiency render the cell 173 hypersensitive or resistant to DoxSL. We decided to focus on DoxSa and DoxDHCer for two 174 reasons. First, we have more information about the effect of acyl chain length on the toxicity 8 of DoxDHCer than that of DoxmetDHCer. Second, we could minimize the amount of DoxSa 176 consumed for the screen by using the strain expressing CerS3, which is the most sensitive 177 strain to DoxSa, as a background strain. The screen was performed by first introducing CerS3 178 into every single yeast strain in the knockout or hypomorphic (DAmP) allele library using 179 automated approaches [26, 27] . Then, the resulting library, in which each strain expressed 180 CerS3 and had one mutant allele, was replica plated onto an agar medium supplemented with 181 different concentrations of DoxSa. Two concentrations were chosen, such that hypersensitive 182 or resistant mutants were revealed prominently at the lower or the higher concentration, 183 respectively. Colony size was scored as a measure of fitness of the mutants (Fig 3A) . 184 The library covered 79.5% of non-essential genes and 68.8% of essential genes (S2A Fig) . 185 Quality control assessments revealed that the extents of biases and technical variabilities in 186 the screen were below our tolerance limits (S2B- F Fig) . The screen revealed that deletion of 187 genes that are required for efficient import of sphingoid base (Δfaa1) or synthesis of very 188 long-chain fatty acyl-CoA (Δelo3, Δ fat1) rendered the cell resistant to DoxSa (Fig 3B) . Since 189 efficient synthesis of C 26 -DoxDHCer from DoxSa requires the two processes, this finding 190 validates that changes in fitness of the mutants in the screen were mainly due to the high 191 toxicity of C 26 -DoxDHCer.
192
Gene ontology (GO) enrichment analysis of resistant genes (defined as genes whose Z-score 193 of colony size ratio > 3, Z-score of solvent-treated colony size > -3.5, CV of colony size ratio 194 < the 50% percentile) using the GOrilla tool [28, 29] showed that there is no enrichment of 
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During the examination of individual genes, we found that the identities of about 10% of the 200 9 mutants in the library could not be confirmed by colony PCR. Furthermore, several freshly 201 generated mutants failed to show the same responses to DoxSa as those indicated by the 202 result of the screen. These findings raised a concern that the mutants in the library had 203 accumulated too many suppressors, thus preventing us from obtaining insights into the MoA 204 of DoxSL.
206
Genome-wide genetic screen of transposon-insertion mutants (SATAY) 207 To ensure that we did not miss key gene products involved in the MoA of DoxSL, we 208 decided to perform another genome-wide genetic screen with an independent method in 209 which the library is freshly-generated. The method is termed SAturated Transposon Analysis 210 in Yeast (SATAY) [31] . The screen was performed by first inducing random insertion of a 211 transposon from a plasmid into the genome of the CerS3 strain. The mutagenesis was 212 performed in a large number of cells to generate a saturated transposon-insertion library.
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Then, the library was divided and subjected to a two-round treatment with DoxSa at different 214 concentrations. Two concentrations were chosen for the same purpose as that in the screen of 215 knockout and DAmP mutants. The number of deep sequencing reads was used as a measure 216 of fitness of the mutants (Fig 3C) . 217 The transposon insertion mutated 91.5% of non-essential genes and 52.5% of essential genes This finding validates that changes in fitness of the mutants in the screen were mainly due to 225 the high toxicity of C 26 -DoxDHCer. 226 We performed various data analyses ranging from enrichment analyses to examination of 227 individual transposon insertion sites. Furthermore, we scrutinized genes that were in the 228 bottom or top 200 of the fitness ranks and that were revealed by the two genetic screens ( Fig   229   3E and 3F). However, once again, we were unable to formulate a clear hypothesis of the 230 MoA of DoxSL. To allow independent analyses of the datasets by others, all primary data are 231 published here (S1 and S2 Tab). It is possible that the MoA cannot be revealed by genetic 232 screens in which gene products are deleted, disrupted, or reduced. Therefore, we performed a 233 multicopy suppressor screen for gene products whose overproduction alleviates the toxicity 234 of DoxSL. In this screen, the CerS3 strain was transformed with a pool of plasmids, each of 235 which carried 4-5 genes and the 2-micron sequence that maintains a high copy number of the 236 plasmid in the cell. Then, the transformed cells were subjected to a three-round treatment 237 with DoxSa at different concentrations. We found that cultures treated with high 238 concentrations of DoxSa did not gain noticeable density after the second and the third round 239 of treatment (data not shown). Considering that the plasmid library covers 97.2% of the yeast 240 genome with 5.4-fold depth of coverage [32] and that the transformed cells covered the 241 plasmid library with 15.9-fold depth of coverage, this finding suggests that there is no single 242 gene whose overexpression is capable of alleviating the toxicity of DoxSL.
243
Given the results of the three genetic screens, we hypothesized two possibilities of the MoA The assay showed that all mutants were more resistant, to different degrees, to DoxSa at 5 261 μ M than the parent strain (the CerS3 strain) (Fig 4A) . The MS analysis showed that all 262 mutants accumulated less C 26 -DoxDHCer than the CerS3 strain following the DoxSa 263 treatment (Fig 4B) . It also showed that C 26 -DoxDHCer was the only DoxDHCer species 264 whose accumulation levels in all mutants were lower than that in the CerS3 strain (S4A-S4F 265 Fig) . Therefore, the degrees of resistance of the mutants could be attributed to their ability to 266 suppress the accumulation of C 26 -DoxDHCer. However, the degree of resistance and the 267 ability to suppress the accumulation of C 26 -DoxDHCer of the mutants did not correlate 268 perfectly, suggesting that C 26 -DoxDHCer was not the only toxic DoxSL species. This became 269 more apparent at a higher concentration of DoxSa. The degrees of resistance of the mutants at 270 10 μ M of DoxSa (Fig 4A) could not be explained by their ability to suppress the 271 accumulation of C 26 -DoxDHCer (Fig 4B) . Instead, they could be better explained by their 272 ability to suppress the accumulation of all DoxDHCer species, albeit imperfectly (Fig 4C) . and spotted on an agar medium to assay their ability to recover. We found that treating WT 291 and the CerS3 strain with DoxSa at concentrations of 0, 2, 4, and 6 μ M, for 1.5 h, at a cell 292 density of 1 million cells/ml gave a wide range of cell viabilities (Fig 5A) . Therefore, we 293 used these conditions of DoxSa treatment for the phenotypic characterization. induced the formation of multiple micron-sized round bodies that could be stained with 302 phalloidin-Atto488. The microscopy also showed that 2 μ M of DoxSa for 1.5 h gave the 303 same phenotype in the CerS3 strain, albeit to a lesser degree (Fig 5B and 5F ). This result 304 shows that DoxSa treatment disrupts F-actin organization in yeast. However, 4 μ M of DoxSa 305 for 1.5 h was not sufficient to stop the growth of WT (Fig 5A) , demonstrating that the 306 phenotype is not sufficient to cause cell death. sufficient to fragment mitochondria and alter the shape of mitochondria from tubular to 315 spherical without affecting their inheritance from the mother cell to the bud in WT. The 316 microscopy also showed that 2 μ M of DoxSa for 1.5 h gave the same phenotype in the CerS3 317 strain, albeit to a lesser degree (Fig 5C and 5G) . This result shows that DoxSa treatment 318 perturbs mitochondria in yeast. However, 4 μ M of DoxSa for 1.5 h was not sufficient to stop 319 the growth of WT (Fig 5A) are distinct from those of lipid droplets (Fig 5D) . The structures could also be observed in a formation of the structures is independent of neutral lipids and that they are not the canonical 338 lipid droplets. Therefore, we call the structures "hydrophobic bodies". The microscopy also 339 showed that 2 μ M of DoxSa for 1.5 h gave the same phenotype in the CerS3 strain, albeit to a 340 lesser degree (Fig 5D and 5H) . These results show that DoxSa treatment induces the 341 formation of hydrophobic bodies in yeast. However, 4 μ M of DoxSa for 1.5 h was not 342 sufficient to stop the growth of WT (Fig 5A) , demonstrating that the phenotype is not 343 sufficient to cause cell death. was sufficient to induce more severe collapsed cortical ER in the CerS3 strain (Fig 5E and   352 5I). This result shows that DoxSa treatment causes the ER membrane to collapse in yeast. In
353
contrast to the other phenotypes, marked collapse of the cortical ER concurred with marked 354 reduction of cell viability (Fig 5A and 5E) , demonstrating that collapsed ER membrane 355 coincides with cell death. 356 We also tested the effects of DoxSa treatment on the nuclear envelope, the vacuolar 357 membrane, the peroxisomal membrane, and the plasma membrane by confocal microscopy. To gain more insights into the toxicity of DoxSL, we performed lipidomics of WT and the 364 CerS3 strain following the same DoxSa treatments as those for the phenotypic 365 characterization by MS. The lipidomics showed that increased concentrations of DoxSa were 366 accompanied by decreased levels of major membrane lipids in both WT and the CerS3 strain.
367
The lipids were five classes of glycerophospholipid (PC, PI, PS, PE, and CL) (Fig 6A-6E ) 368 and two classes of complex sphingolipid (IPC and MIPC) (Fig 6G and 6H) . In contrast, 369 increased concentrations of DoxSa were accompanied by increased levels of a sphingolipid 370 intermediate, ceramide (Fig 6F) . Compared to those of other lipid classes, the levels of a 371 16 class of complex sphingolipid, M(IP) 2 C were the least affected by increased concentrations of 372 DoxSa (Fig 6I) . Given that the degrees of depletion of the major membrane lipids in WT 373 were comparable to those in the CerS3 strain, this result suggests that DoxSa, not 374 DoxDHCer, accumulation leads to depletion of major membrane lipids. (Fig 7A and 7B) . A time-course lipid analysis by MS following a DoxSa 383 treatment at 6 μ M for up to 3 h showed that the longer the DoxSa treatment, the higher the 384 levels of C 26 -DoxDHCer and total DoxDHCer (Fig 7C and 7D) , demonstrating that the 385 phenomenon is not due to post-cell death events. In addition, deletion of ceramidase (Δypc1 386 Δ ydc1) did not modulate the sensitivity of the CerS3 strain to DoxSa (Fig 7E) , demonstrating 387 that the phenomenon is ceramidase-independent. The phenomenon suggests the dynamics of Since the phenotypes in the CerS3 strain were more severe than those in WT following a 398
given DoxSa treatment (Fig 5B-5I) , the phenotypes could not be fully attributed to elevated 399 levels of DoxSa and depletion of major membrane lipids (Fig 6A-6I) . Also, since the levels 400 of accumulated DoxDHCer did not fully correlate with the severity of the phenotypes (Fig   401   5B-5I, Fig 7A and 7B) , the phenotypes could not be fully attributed to elevated levels of 402 DoxDHCer either. Therefore, the phenotypes must be caused by elevated levels of both DoxDHCer production as DoxSa rapidly reaches its toxic level. We also found that the 
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HR2885 lag1Δ::HIS3 lac1Δ::ADE2 Howard Riezman and sonicated for 5 min using an ultrasonic bath to make stock solutions. The solutions were 511 stored at -20°C. Before use, the solutions were brought to room temperature and sonicated for 512 5 min. 
Genome-wide genetic screen of transposon-insertion mutants (SATAY)
577 Library generation -SAturated Transposon Analysis in Yeast (SATAY) was performed as 578 described before [31] with minor modifications. Briefly, the SATAY CerS3 strain was 579 transformed with pBK257 plasmid containing the transposon. Freshly transformed cells were 580 inoculated into 1 l of SC liquid + 0.2% of glucose + 2% of raffinose -Ura at OD 600 of 0.15 581 and grown at 30°C until saturation (OD 600 of 3-4). Then, the culture was concentrated ten 582 times by centrifugation at 600 ×g for 5 min to obtain final OD 600 of 37. To induce 583 transposition, the cells were plated using glass beads onto 433 8.5-cm Petri dishes of SC agar 584 + 2% of galactose -Ade and incubated at 30°C for 3 weeks. Contaminated plates were 585 removed during the incubation time. Next, colonies were scrapped using a glass rod with 586 minimum amounts of SC liquid + 2% of glucose -Ade, pooled, inoculated into 1 l of SC 587 liquid + 2% of glucose -Ade at OD 600 of 0.125, and incubated at 30°C until OD 600 of 0.5.
588
The library was used immediately.
589
DoxSa treatment -The cells in the library were pelleted at 800 ×g for 5 min, inoculated into 590 pre-warmed 500 ml of SC liquid + 2% of glucose -Ade supplemented with DoxSa at OD 600 591 of 0.1, and incubated at 30°C until saturation. The treatment was repeated once. Next, the 592 cells were harvested by centrifugation at 2,500 ×g 4°C for 5 min and stored at -80°C. 
